Aline M. Betancourt

A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype

Ruth S. Waterman, Suzanne L. Tomchuck, Sarah L. Henkle et al. · PLoS ONE · 2010 · 1.2K citations · Full text

Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis

Ruth S. Waterman, Sarah L. Henkle, Aline M. Betancourt · PLoS ONE · 2012 · 190 citations · Full text

A Nonhuman Primate Model of Lung Regeneration: Detergent-Mediated Decellularization and Initial <i>In Vitro</i> Recellularization with Mesenchymal Stem Cells

Ryan W. Bonvillain, Svitlana Danchuk, Deborah E. Sullivan et al. · Tissue Engineering Part A · 2012 · 164 citations · Full text

Tissue Engineering, Regeneration, Engineering +29

New concepts on the immune modulation mediated by mesenchymal stem cells

Bruce A. Bunnell, Aline M. Betancourt, Deborah E. Sullivan · Stem Cell Research & Therapy · 2010 · 130 citations · Full text

Cell Therapy, Adult Stem Cell, Immune Regulation +19

Anti-Inflammatory Mesenchymal Stem Cells ( <i>MSC2</i> ) Attenuate Symptoms of Painful Diabetic Peripheral Neuropathy

Ruth S. Waterman, Jenny Morgenweck, Bobby D. Nossaman et al. · Stem Cells Translational Medicine · 2012 · 85 citations · Full text